GeneThera (GeneThera) Scaled Net Operating Assets : -2,576.00 (As of Sep. 2022)

View and export this data going back to 2000. Start your Free Trial

What is GeneThera Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GeneThera's operating assets for the quarter that ended in Sep. 2022 was $0.00 Mil. GeneThera's operating liabilities for the quarter that ended in Sep. 2022 was $7.73 Mil. GeneThera's Total Assets for the quarter that ended in Jun. 2022 was $0.00 Mil. Therefore, GeneThera's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2022 was -2,576.00.

GeneThera Scaled Net Operating Assets Historical Data

The historical data trend for GeneThera's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneThera Scaled Net Operating Assets Chart

GeneThera Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Scaled Net Operating Assets

Get a 7-Day Free Trial

-25.20

-160.63

-327.05

-613.50

GeneThera Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Scaled Net Operating Assets	Get a 7-Day Free Trial															-805.11	-920.25	-1,248.33	-1,902.25	-2,576.00

Competitive Comparison of GeneThera's Scaled Net Operating Assets

For the Biotechnology subindustry, GeneThera's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneThera's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneThera's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where GeneThera's Scaled Net Operating Assets falls into.

GeneThera Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GeneThera's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(0.006	-	7.368)	/	0.012
=	-613.50

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.006	-	0
=	0.006

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.179	-	0	-	0.811
=	7.368

GeneThera's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2022 )
=	(Operating Assets (Q: Sep. 2022 )	-	Operating Liabilities (Q: Sep. 2022 ))	/	Total Assets (Q: Jun. 2022 )
=	(0.001	-	7.729)	/	0.003
=	-2,576.00

where

	Operating Assets		(Q: Sep. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.001	-	0
=	0.001

	Operating Liabilities		(Q: Sep. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.543	-	0	-	0.814
=	7.729

GeneThera Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of GeneThera's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneThera (GeneThera) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneThera Inc (OTCPK:GTHR) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

3051 W 105th Avenue, Suite 350251, Westminster, CO, USA, 80035

Website

http://genetherainc.com

GeneThera Inc is a biotechnology company using its proprietary molecular sciences and technologies dedicated to eradicating diseases such as COVID-19, Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. It focuses on developing novel molecular diagnostic tests, therapeutics, and vaccines through its proprietary robotic technologies. Its Molecular Robotic/AI Platform and Therapeutic strategy (MORAPAT) is designed to prevent the spread of disease from animals and at the same time, allow better control of zoonotic infectious agents. The company has also developed a molecular system for the detection of Mycobacterium Avian Paratuberculosis in the milk of infected dairy cows.

Executives

Avel Kolesnikov	director	11353 COLONY CIRCLE, BROOMFIELD CO 80020
Mcnece Elmer Roy Jr	10 percent owner	632 CANTRILL DRIVE, DAVIS CA 95616
Fidra Holdings Ltd	10 percent owner	CABLE BEACH COURT, ONE WEST BAY STREET, NASSAU BAHAMAS C5 00000
Steven Michael Grubner	director, officer: Chief Financial Officer	728 S. PRAIRIE AVENUE, BARRINGTON IL 60010
Antonio Milici	director, 10 percent owner, officer: Chief Executive Officer	3930 YOUNGFIELD, WHEAT RIDGE CO 80033
Tannya L Irizarry	director, 10 percent owner, officer: Chief Administative Officer	11880 ANTLER TR, LITTLETON CO 80127

GeneThera (GeneThera) Headlines

No Headlines